Bayer could be granted conditional U.S. antitrust approval for its planned takeover of Monsanto as soon as Tuesday, clearing a major hurdle for the $62.5 billion deal, a person familiar with the situation told Reuters. Bayer has already come to an agreement in principle on what it would take to win approval from the U.S. Department of Justice (DoJ), after adjusting the planned divestment of assets to include digital farming to assuage antitrust concerns. Both Bayer and the DoJ declined to comment. …read more
Source:: Yahoo Finance
